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Abstract
Background: The availability of specific markers expressed in different regions of the developing
nervous system provides a useful tool for the study of mouse mutants. One such marker, the
transcription factor Pax2, is expressed at the midbrain-hindbrain boundary and in the cerebellum,
spinal cord, retina, optic stalk, and optic chiasm. We recently described a group of diencephalic cells
that express Pax2 as early as embryonic day (E) 10.5, and become part of the eminentia thalami by
E11.5. The discovery of this previously undescribed cell population prompted us to examine Pax2
protein expression in the developing mouse forebrain in more detail.
Results: We determined the expression pattern of Pax2 in the forebrain of wild type mouse
embryos between E10.5 and postnatal day (P) 15. Pax2 expression was detected in the septum of
the basal forebrain, hypothalamus, eminentia thalami and in the subfornical organ. To evaluate Pax2
as a marker for septal cells, we examined Pax2 expression in Pax6Sey/Sey mutants, which have an
enlarged septum. We found that Pax2 clearly marks a population of septal cells equivalent to that
seen in wild types, indicating its utility as a marker of septal identity. These cells did not express
the GABAergic marker calbindin nor the cholinergic marker choline acetyltransferase and were not
detectable after P15.
Conclusion:  Pax2 is expressed in populations of cells within the developing septum,
hypothalamus, and eminentia thalami. It seems especially useful as a marker of the telencephalic
septum, because of its early, strong and characteristic expression in this structure. Further, its
expression is maintained in the enlarged septum of Pax6Sey/Sey mutants.
Background
Pax2 is a member of the Pax family of transcription factors
[1,2], characterised by the presence of a paired-type home-
odomain [3,4]. Pax2 is expressed in a number of different
organs in the developing mouse embryo, including the
ureteric bud, kidneys [1,2] and otic vesicle [5]. In the
developing nervous system, Pax2  is first detected at
embryonic day (E) 7.5 in the neural plate, in the area of
the presumptive midbrain-hindbrain region [6]. At E8.0,
Pax2 displays a broad expression domain in this region,
which by E9.5 is restricted to the isthmus at the midbrain-
hindbrain boundary [6]. Pax2 expression in the isthmus
ceases after E11 [7]. In the cerebellum, Pax2 is specifically
expressed by a subset of cerebellar GABAergic interneu-
rons and their precursors, from E12 until the end of cere-
bellar development (postnatal day 15) [8]. In the spinal
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cord, Pax2 expression is found in the intermediate zone as
early as E10.5 [5,7]. In the developing eye,Pax2 expression
is initiated at E9 in the ventral half of the optic vesicle. By
E11, after invagination of the optic vesicle, both Pax2
transcript and protein are detected at high levels in the
ventral opening of the optic cup, the optic fissure, and the
optic stalk, ending at the border with the diencephalon
[5,7,9,10]. After E12.5, Pax2 protein expression is still
present in the ventral optic cup, although the level is
decreased, and it is no longer detected after E16.5 [9].
Pax2 is also expressed in glial cells in the optic nerve
[5,9,10].
Pax6, another member of the Pax family, is expressed in
the dorsal telencephalon, diencephalon, hindbrain
regions and spinal cord [11] and throughout the develop-
ing optic cup, but is absent from the optic stalk and optic
nerve [12]. Mutant mice lacking functional Pax6 protein
(Pax6Sey/Sey mice), display a large range of nervous system
defects, including absence of eyes [13], disruption of dor-
soventral telencephalic patterning [14,15] and the dien-
cephalic-mesencephalic boundary [16,17]. Pax6 and Pax2
are expressed in neighbouring, but mutually exclusive
domains in the developing eye (with the exception of the
ventral optic cup), [18], and in the diencephalic-mesen-
cephalic region [19]. In the developing spinal cord, Pax2
is expressed by many types of early differentiated neurons,
located in the mantle zone and surrounding Pax6-positive
neural precursors in the ventricular zone [20]. Fewer Pax2-
positive interneurons are found in the Pax6Sey/Sey mutant,
indicating that Pax6 is required for their development
[20].
We have recently described a group of diencephalic cells
at the border region between the diencephalon and the
telencephalon that expresses Pax2 protein at E10.5 [21].
At E12.5, these Pax2-immunopositive cells form a distinct
cell population at the most dorso-lateral tip of the emi-
nentia thalami [21], a diencephalic structure that joins the
ventral diencephalon to the dorsal and ventral telen-
cephalon [22-24]. Here, we describe previously unidenti-
fied areas of Pax2 expression in the developing mouse
forebrain. Further, we show that Pax2 expression is main-
tained in the septum of Pax6Sey/Sey mutants, which are
known to have an enlarged septum. This study highlights
the value of Pax2 as a novel marker of forebrain develop-
ment.
Results
Domains of Pax2 expression in the developing mouse 
forebrain
We examined Pax2 expression in the early forebrain using
immunohistochemistry on sagittal sections of E10.5 and
E11.5 embryos (Fig. 1). At E10.5, a few Pax2-immunopo-
sitive cells were detected within the ventral telencephalon
in lateral sagittal sections (Fig. 1A, a-arrowheads), with
the staining becoming more intense in mid-sagittal sec-
tions (Fig. 1a'). In addition, a small population of Pax2
immunopositive cells was detected in the neuroepithe-
lium of the anterior hypothalamus, adjacent to the optic
Pax2 protein expression in the mouse forebrain at E10.5 and  E11.5 Figure 1
Pax2 protein expression in the mouse forebrain at 
E10.5 and E11.5. A-B, a-b: E10.5 sagittal sections showing 
Pax2 expression in the developing forebrain. In the ventral 
telencephalon, a few Pax2-positive cells can be detected in 
lateral sections (arrowheads in a) and become more abun-
dant in more medial sections (a'). A few Pax2-positive cells 
are detected in the hypothalamus, close to the strongly Pax2-
positive optic recess (or) area (B, b). The previously 
described staining in the future eminentia thalami of the dien-
cephalon (asterisk in A) and the optic cup (arrowhead in A) 
are also shown. C, c: E11.5 sagittal sections revealing strong 
Pax2 expression in the developing septum (Se). No Pax2 
expression is detected in the neighbouring lamina terminalis 
(LT) (arrow in c) at this developmental stage. Pax2-immuno-
positive cells are also found in the anterior hypothalamus 
(arrowheads in c) and may originate from the ventral neu-
roepithelium of the optic recess area (or). Expression in the 
eminentia thalami is not shown. Note the Pax2 expression in 
the spinal cord (SC) (arrows in C). a, b and c are high power 
images of the boxed areas in A, B and C respectively. a' is a 
high power image of a sagittal section at a more medial level 
than that depicted in a. Scale bars: C, 400 μm; A, B, c, 200 
μm; a, a', b, 50 μm.BMC Developmental Biology 2008, 8:79 http://www.biomedcentral.com/1471-213X/8/79
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recess area (Fig. 1B,b). At E11.5, strong Pax2 expression
was found in the developing septum (Fig. 1C,c) with no
Pax2-immunopositive cells detected in the neighbouring
lamina terminalis (arrow in Fig. 1c). As in E10.5 embryos,
a number of Pax2-positive cells were found close to the
base of the hypothalamus but also in more dorsal areas of
the anterior hypothalamus (Fig. 1C,c). At both E10.5 and
E11.5, Pax2 expression was found in previously described
regions such as the ventral neuroepithelium of the optic
recess (Fig. 1B,b,C,c) [5,7,9,10], the optic cup (arrowhead
in Fig. 1A and not shown) [5,7,9,10] and near the dien-
cephalic-telencephalic boundary (asterisk in Fig. 1A and
not shown), which will give rise to the eminentia thalami
[21].
Pax2 protein expression was then examined at E12.5, on
coronal and sagittal sections along the caudo-rostral axis
of the developing mouse forebrain (Fig. 2). The strongest
expression domain of Pax2 was detected in the telen-
cephalon. The Pax2 antibody labelled most cells of the
septal neuroepithelium, located in close proximity to the
dorso-medial telencephalon (Fig. 2A,a). This strong and
characteristic Pax2 expression in the septum was also
observed in sagittal sections, in the region where the lam-
ina terminalis joins the septum (Fig. 2D,d). Only a few
Pax2-immunopositive cells were detected within the
neighbouring lamina terminalis (arrows in Fig. 2d).
Specific Pax2 expression was also detected in small clus-
ters of cells in regions of the hypothalamus. The Pax2 anti-
body labelled a group of cells located at the lateral
hypothalamic area (Fig. 2B, arrowheads in b), and a nar-
row strip of cells parallel to the anterior hypothalamic
ventricular zone (Fig. 2B, arrows in b'). A few Pax2-immu-
nopositive cells were also detected along the base of the
hypothalamus, excluding the midline region (Fig. 2b,
arrows). These groups of Pax2-positive cells can also be
distinguished in a sagittal plane (Fig. 2D,d'). The cell pop-
ulations indicated by the arrowheads and small arrows
(Fig. 2d'), located just above the optic recess area, corre-
spond to the respective populations indicated in Fig. 2b.
The Pax2 positive cells located close to the third ventricle,
indicated with large arrows in Fig. 2d', correspond to
those shown in Fig. 2b'. In coronal sections of the caudal
forebrain, specific Pax2 expression was also detected in a
small cluster of cells resembling a nucleus in the neuroep-
ithelium of the anterior hypothalamus (Fig. 2C,c). In
accordance with previous reports, Pax2 expression was
also detected in the ventral neuroepithelium of the optic
recess area at the base of the hypothalamus (Fig. 2d', aster-
isk), retina (not shown) [5,7,9,10] and eminentia thalami
at the level depicted in Fig. 2B (not shown) [21].
Double immunofluorescence with Pax2 and β-tubulin III
(Tuj1), a marker of early neural differentiation found in
Pax2 protein expression in the mouse forebrain at E12.5 and  E13.5 Figure 2
Pax2 protein expression in the mouse forebrain at 
E12.5 and E13.5. A-C: Low power views of coronal E12.5 
forebrain sections immunoreacted with Pax2; the boxed 
areas are shown at higher magnification in panels a-c. D: Low 
power view of a sagittal E12.5 section immunoreacted with 
Pax2. Note the strong expression of Pax2 in the isthmic 
region (Is) and the spinal cord (SC), in accordance with previ-
ous reports. d, d' higher magnification of the boxed areas in 
D. A, a, d: Strong Pax2 expression is detected in the septum 
(Se) of the basal forebrain, mainly in the septal neuroepithe-
lium. A few Pax2-positive cells are detected in the lamina ter-
minalis (LT) (arrows in d). b-c, d': Pax2 is detected in groups 
of cells found in the lateral hypothalamic area (arrowheads in 
b and d') and in the anterior hypothalamic neuroepithelium 
(arrows in b' and d', c). These cell populations might origi-
nate from cells located at the base of the hypothalamus 
(small arrows in b and d'), Pax2 expression can also be seen 
in the ventral neuroepithelium of the optic recess (asterisk in 
d'), as previously described. E-G: Low and high power 
images of E13.5 coronal sections reveal strong Pax2 expres-
sion in the septum, mainly in the neuroepithelium (F). A few 
immunopositive cells are found in the differentiating layer of 
the septum (G). The boxed areas in the inset panels in E-G 
indicate the areas shown in the respective high power 
images. A-C and E-G are sections from the same specimens 
respectively. Scale bars: D, E-G-insets, 1000 μm; A-C, 500 
μm; a, d', F-high power, 200 μm; b-c, d, E, G-high power, 
50 μm.BMC Developmental Biology 2008, 8:79 http://www.biomedcentral.com/1471-213X/8/79
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neurites, revealed that a very low proportion of septal cells
labelled with Pax2 co-expressed β-tubulin III (Fig 3A),
suggesting that the majority of the Pax2-positive cells in
this region are neural precursors. This was confirmed by
double immunohistochemistry with Pax2 (black, nuclear
staining) and nestin (brown, filament staining), an inter-
mediate filament protein found in radial glia, which
showed that the β-tubulin III-negative/Pax2-positive cells
in the septum express nestin (Fig. 3B). In the hypothala-
mus, most of the Pax2-positive cells found close to the
ventricle (panels 2b' and 2c) are also positive for β-tubu-
lin III, showing that these cells are newly formed neurons
(Fig. 3C). The Pax2-positive population indicated by
arrowheads in panels 2b and 2d' also expressed β-tubulin
III, even more extensively than the other hypothalamic
Pax2-positive cells (Fig. 3D). Finally, the Pax2-positive
cells located close to the hypothalamic ventral midline
(small arrows in panels 2b and 2d') did not express β-
tubulin III, but were positive for nestin, indicating that
they correspond to neural progenitors (data not shown).
At E13.5, Pax2 was detected in cells located at the septal
midline (Fig. 2E). Expression was strong and specifically
confined to the septal neuroepithelium, at the point
where the septum joins with the future hippocampus via
the lamina terminalis (Fig. 2F). At more rostral telen-
cephalic levels, a small number of Pax2-immunopositive
cells were found in the differentiating field of the septum
(Fig. 2G).
Pax2 expression in the hypothalamus at this age was sim-
ilar to that seen at E12.5, with the exception that the
immunopositive cells in the lateral hypothalamic area
and the base of the hypothalamus shown in Fig. 2b, were
no longer detectable (data not shown). No Pax2-immu-
nopositive cells were found in the eminentia thalami after
E13.5 (not shown).
At E14.5, coronal telencephalic sections revealed similar
Pax2 expression to that described at E13.5 (data not
shown). As for the earlier ages examined, Pax2 expression
was mainly confined to the septum, in the neuroepithe-
lium adjacent to the lamina terminalis, as depicted in the
mid-sagittal section in Fig. 4A and 4a. In the E14.5
hypothalamus, Pax2 expression was limited to a very nar-
row band of cells, localized in the differentiating field of
the anterior hypothalamus and reaching the medial horn
of the lateral ventricle (Fig. 4B, arrows in b). We could not
detect these immunopositive cells in the coronal plane,
probably because of their narrow field of expression.
Expression was also found at the optic recess area as pre-
viously described [9], (arrowhead in Fig. 4A,B).
By E16.5, the main Pax2 expression domain in the devel-
oping septum was located in the differentiating field of
the medial septum. It was mainly found in a stripe-like
cell arrangement, parallel to the midline and surrounded
by the fibre bundles of the fornix (Fig. 4D). At this devel-
opmental stage, the only Pax2 expression detected in the
hypothalamus was in the optic stalk epithelium, just
above the optic chiasm region (Fig. 4C), in a few cells of
the hypothalamic neuroepithelium, adjacent to the supra-
chiasmatic nucleus (arrowheads in Fig. 4C) and in a few
scattered cells in the medial preoptic nucleus.
During early postnatal development only a few Pax2-pos-
itive cells were detected in the forebrain. At postnatal day
Pax2 is primarily expressed in neural progenitors in the sep- tum and in early differentiated neurons in the hypothalamus Figure 3
Pax2 is primarily expressed in neural progenitors in 
the septum and in early differentiated neurons in the 
hypothalamus. A: Double immunofluorescence with Pax2 
(red) and β-tubulin III (Tuj1) (green) on a sagittal E12.5 telen-
cephalic section shows that only a minority of Pax2-positive 
cells in the septum also express Tuj1, an early marker of dif-
ferentiated neurons. This is further confirmed with double 
immunohistochemistry with Pax2 (black) and nestin (brown) 
(B), revealing that these Pax2-positive cells have nestin-posi-
tive filaments. Panels (A) and (B) show correspond to high 
power images taken within the region depicted in Fig. 2D, 
d. In the hypothalamus (C, D), most Pax2-positive cells 
express the early neural marker β-tubulin III (green), showing 
that they correspond to early generated neurons. Pax2-posi-
tive cells in (C) correspond to those shown in Fig. 2b', and 
those in (D) correspond to the cells indicated by arrowheads 
in Fig. 2b. The position of the ventricular zone (VZ) is indi-
cated in sections A, C and D. Scale bars: A, 20 μm; B-D, 5 
μm.BMC Developmental Biology 2008, 8:79 http://www.biomedcentral.com/1471-213X/8/79
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(P) 1, Pax2 immunopositive cells were detected scattered
in the most caudal sections of the septal area, at the level
where the fornix is found in proximity to the anterior
commissure (Fig. 5A). As at E16.5, a few cells were found
close to the fornix, in the medial septal area, as well as in
the border zone between the medial and lateral septum
(Fig. 5A,B). Pax2 also labelled the medial preoptic nucleus
of the hypothalamus (Fig. 5B). At P8, a similar expression
pattern was observed (Fig. 5C, D). In addition, Pax2 was
detected in the subfornical organ (Fig. 5E), one of the cir-
cumventricular organs of the brain involved in fluid bal-
ance [25]. Pax2 expression was no longer detected at P15
(not shown).
Expression of Pax2 in the septum in Pax6Sey/Sey mutants
To validate Pax2 as a marker of the septal neuroepithe-
lium, we used the Pax6Sey/Sey  mutant, which has been
shown to have an enlarged septum [15]. Using double
immunofluoresence, we first examined expression of
Pax2 and Pax6 in E12.5 wild type embryos. In rostral tel-
encephalic sections, Pax6 was strongly expressed in the
dorsal, lateral and ventral pallium, with its most ventral
Pax2 protein expression in the mouse forebrain at E14.5 and  E16.5 Figure 4
Pax2 protein expression in the mouse forebrain at 
E14.5 and E16.5. A, a: Low and high power images of an 
E14.5 sagittal section showing strong Pax2 staining in the 
neuroepithelium of the septum (Se) adjacent to the foramen 
of Monro (FM) in an E14.5 sagittal section. This intense Pax2 
staining is observed at the level where the lamina terminalis 
(LT) joins the septum. a shows a higher magnification of the 
boxed area in panel A. B, b: In more lateral sagittal sections 
Pax2 expression is found in a cell population (arrows) within 
the anterior hypothalamus (AH) reaching the medial horn 
(mh) of the lateral ventricle. b shows a higher magnification 
of the boxed area in panel B. C: E16.5 coronal section show-
ing Pax2 expression around the optic chiasm (oc) region, in 
the optic stalk epithelium and in a few cells of the hypotha-
lamic neuroepithelium next to the suprachiasmatic nucleus 
(SCH) (arrows). D: E16.5 coronal section showing Pax2 
expression in the differentiating layer of the medial septum 
surrounded by the axonal bundles of the fornix (fx). Scale 
bars: A, B, 1000 μm; a, C, D, 200 μm; C-inset, 250 μm; b, 
100 μm.
Pax2 protein expression in the mouse forebrain during early  postnatal development Figure 5
Pax2 protein expression in the mouse forebrain dur-
ing early postnatal development. A-E: Coronal fore-
brain sections immunostained for Pax2 at P1 (A-B) and at P8 
(C-E), showing the presence of few disperse Pax2-positive 
cells in the septal area (Se) (A-C, high power in D), the 
medial preoptic nucleus (po) (asterisk in A and B), and the 
subfornical organ (SFO) (arrow in E). The fibre tracts are 
indicated in A and B for orientation purposes (ac, anterior 
commissure; cc, corpus callosum; fx, fornix). The boxed 
areas in A and C delineate the high power images depicted in 
B and D respectively. Scale bars: A, C, 100 μm; B, E, 25 μm; 
D, 12.5 μm.BMC Developmental Biology 2008, 8:79 http://www.biomedcentral.com/1471-213X/8/79
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expression domain expanding into the lateral ganglionic
eminence, just below the pallial-subpallial boundary (Fig.
6A), as previously described [11,14,24]. Pax6 was
expressed at lower levels in the medial pallium but did not
overlap with the expression domain of Pax2 in the septal
neuroepithelium (Fig. 6A, arrows).
Using Pax6Sey/Sey mutant embryos, we examined whether
loss of Pax6 affects Pax2 expression in the septum. No
gross changes in the extent of the main Pax2 expression
domain were observed, although the intensity of Pax2
staining appeared reduced in Pax6Sey/Sey  mutants com-
pared to the wild type (area between arrows in Fig. 6B,C).
In addition, Pax2 expression was observed in a more dor-
sal area compared to wild type, revealing a larger septum
in the mutant (compare areas between dotted lines in Fig.
6B and 6C), in accordance with previous published data
[15]. This result was consistent in all mutants examined (n
= 6). Double immunofluorescence with antibodies for
Pax2 and the septal marker Lim1 (also known as Lhx1),
using an antibody that detects both Lim1 and Lim2
(Lim1/2) [26,27], showed that in both wild types and
Pax6Sey/Sey mutants, Pax2 expression was confined within
the Lim1/2 positive domain (Fig. 6D,E). This shows that
the shifted area of Pax2 expression observed in the Pax6Sey/
Sey mutant most likely corresponds to ventral telencephalic
tissue, and not to ectopic Pax2 expression in the dorsal tel-
encephalon.
Figure 6
The Pax2 expression domain in the telencephalic septum is  located in a more dorsal position in the Pax6Sey/Sey mutant  than in wild type Figure 6
The Pax2 expression domain in the telencephalic 
septum is located in a more dorsal position in the 
Pax6Sey/Sey mutant than in wild type. Pax2 expression in 
the telencephalic septum in E12.5 wild type (wt) (A, B, D) 
and Pax6Sey/Sey mutant (Sey) (C, E) coronal sections. A: Dou-
ble immunofluorescence with Pax2 (red) and Pax6 (green) 
reveals that the two proteins are expressed in non-overlap-
ping, mutually exclusive domains. The arrows in A indicate 
the ventral and dorsal limits of Pax6 and Pax2 expression 
respectively. B-C: Pax2 expression in wt and Sey embryos, 
showing that the Pax2 expression domain is shifted dorsally 
in the Sey mutant (C) compared to wt (B). The septum and 
the Pax2 expression domain are indicated by dashed lines 
and arrows respectively. D-E: Double immunofluorescence 
with Pax2 (red) and Lim1/2 (green) in the septum shows that 
Pax2 expression is found within the Lim-positive domain in 
both wild types (D) and Sey mutants (E), suggesting that the 
shifted Pax2 expression domain in the Sey mutant is still 
within the limits of the ventral telencephalon. Note that pan-
els B and C correspond to slightly more rostral sections than 
those shown in D and E respectively. Scale bars: A, B, C, 200 
μm; D, E, 100 μm.BMC Developmental Biology 2008, 8:79 http://www.biomedcentral.com/1471-213X/8/79
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Pax2-positive cells in the early postnatal septum do not 
express markers of GABA-ergic or cholinergic neurons
To gain further insight into the neurochemical properties
of the differentiated Pax2 cells detected in the septum, we
examined co-expression of Pax2 and markers of GABA-
ergic and cholinergic neurons, the principal neuronal
types of this structure [28-30].
To examine whether the Pax2-positive cells detected post-
natally might be GABA-ergic we performed double immu-
nostaining experiments with Pax2 and calbindin, a
calcium-binding protein that has been shown to label a
large population of GABA-ergic somatospiny neurons in
the adult septum [31,32]. A large number of neurons were
labelled with an antibody for calbindin in the postnatal
septum (Fig. 7B). However, Pax2-positive cells did not
colocalize with calbindin, neither at P1 (not shown) nor
at P8 (Fig. 7A–C). To examine whether the Pax2 immu-
nolabelled neurons might be cholinergic, we performed
double immunostaining experiments with appropriate
markers. At P1, we examined co-expression of Pax2 and
Islet1, a protein that has been shown to label some popu-
lations of cholinergic septal neurons [33,34]. No co-local-
isation of these two proteins was detected (not shown).
Choline acetyltransferase (Chat), the acetylcholine-syn-
thesizing enzyme in cholinergic neurons, can not be
detected clearly in septal neurons by means of immuno-
histochemistry before P8 [28,30]. We examined co-locali-
zation of Chat and Pax2 at P8 by means of double
immunostaining (immunohistochemistry followed by
immunofluorescence). As shown in Fig. 7, at P8 a few cells
in the septum start expressing Chat but do not express
Pax2 (7D–F).
Discussion
Specific markers expressed in different regions of the
developing nervous system are widely used as tools to
study neural development. Here, the expression of Pax2, a
well-studied marker of the isthmus, spinal cord and devel-
oping eye, has been re-examined, using a polyclonal anti-
Pax2 expression in the medial septum does not co-localise with that of calbindin and choline acetyltransferase (Chat) Figure 7
Pax2 expression in the medial septum does not co-localise with that of calbindin and choline acetyltransferase 
(Chat). A-C: Double immunohistochemistry with Pax2 (black) (A) and calbindin (magenta) (B) on P8 coronal sections reveal 
the presence of both calbindin-positive and Pax2-positive neurons in the septal area, but not co-expression of these proteins 
(C). Similarly (D-F), septal neurons that express Pax2 (green) (D) and Chat (brown) (E), do not co-express these proteins (F). 
The panels are high powers of the level depicted in Fig. 5C. Scale bar for all panels, 10 μm.BMC Developmental Biology 2008, 8:79 http://www.biomedcentral.com/1471-213X/8/79
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body, and novel areas of Pax2 protein expression have
been identified in the ventral telencephalic septum and
the developing hypothalamus. The polyclonal antibody
used in the present study recognizes the same epitope
described by Dressler and Douglass (1992) and has been
previously used by several groups to characterize Pax2
protein distribution [2,7,9]. In this study, the use of paraf-
fin sections subjected to microwaving for antigen
retrieval, in contrast to the cryostat sections used previ-
ously, may have allowed the identification of the previ-
ously undescribed domains of Pax2 expression.
Pax2 staining in the hypothalamus is first detected at
E10.5 and comprises a few cells in the ventricular zone,
dorsal to the optic recess. By E11.5, Pax2 positive cells are
found in a region that extends from the area of the optic
recess to the lateral ventricle that will give rise to the ante-
rior hypothalamus. Comparison of the distribution of
Pax2 positive cells in this region at E12.5 and E10.5 sug-
gests that they might follow a migratory path towards dor-
sal regions of the anterior hypothalamus. By E14.5, fewer
Pax2-positive cells are present than at E12.5, and these are
restricted to the dorsal anterior hypothalamus. Pax2 is
expressed in the optic stalk, a structure that joins the optic
cup to the brain, and that ends at the base of the hypoth-
alamus [5,7,9,10]. It is therefore possible that the small
population of Pax2/β tubulin III-positive cells in the
developing anterior hypothalamus described here, may
arise from the optic stalk and collaborate with other cellu-
lar hypothalamic cues in guiding the trajectory of the
optic nerve.
Pax2 is also expressed in the eminentia thalami, a tran-
sient developmental structure of unknown function [35]
that joins the ventral diencephalon to the telencephalon
[22-24]. Pax2 expression in the eminentia thalami is first
detected at E10.5 at the dorsal border between the dien-
cephalon and telencephalon [21], and this staining can
not be detected after E13.5. The Pax2-positive cells in the
eminentia thalami do not express β-tubulin III, indicating
that they are most likely to be neuronal precursors. The
early appearance of these cells at the diencephalic-telen-
cephalic boundary (this study and [21]) suggests that they
might be important for the formation of this boundary.
Consistent, high levels of Pax2 expression were also
observed in the septum of the basal forebrain. Pax2 is first
expressed at E10.5 by a small number of cells located in
the ventral telencephalon. It seems likely that these cells
give rise to the Pax2-positive population observed in the
septal area one day later. By E12.5, septal Pax2 expression
although strong, is confined to the septal neuroepithe-
lium, mainly at levels proximal to the lamina terminalis.
Only a few Pax2-positive cells are observed in the differen-
tiating layer of the septum. Septal expression is also
observed at later developmental stages, but by E16.5 it is
downregulated and becomes restricted to a small popula-
tion of differentiated cells in the medial septum. During
septal development in rodents, cells migrate from the lat-
eral ventricle towards the midline. The medial nucleus is
one of the first nuclei formed in the septum [36-38].
Therefore, it is possible that the sparse Pax2-positive cells
observed at E16.5 correspond to the Pax2-positive cells
observed in the differentiating field of the septum
between E12.5 and E14.5 (Fig. 3A, 2G and not shown).
Pax2 is still expressed by a few cells located in the medial
and lateral septal areas during postnatal development and
it is not detected after P15. The majority of neurons in the
medial and lateral septum are cholinergic or GABA-ergic
[28,30,31]. Mature cholinergic neurons express the
enzyme choline acetyltransferase (Chat) [39,40], whose
expression in the septum becomes detectable at around
P8 [28,30]. At this age, Pax2 expressing neurons are still
found in the septal region but do not co-express Chat, sug-
gesting that these cells might not be of the cholinergic
type. However, it is also possible that the Pax2 immunop-
ositive cells might develop into cholinergic neurons at
later time points when Chat expression has increased and
Pax2 expression has been turned off. Similarly, calbindin
is expressed by a large number of somatospiny GABA-
ergic neurons in the adult septum [31,32] and it is present
in the postnatal septal area, but it does not co-localize
with Pax2, indicating that the Pax2 septal neurons are not
of this particular GABA-ergic type. As there many different
types of GABA-ergic neurons in the septum [41], it is pos-
sible that the Pax2-positive cells might develop into a dif-
ferent type, such as the septohippocampal projection
neurons, a prominent GABA-ergic population comprised
of parvalbumin-positive cells [28,42,43]. Although a few
of these cells are first detected at around P8 [28,30], when
Pax2 expression is still detectable in the septum, they
become clearly visible after P15, when Pax2 expressing
cells are no longer present in the septum. Again, this
expression pattern precludes us from being able to draw
conclusions about the specific neuronal type of these cells
based solely on immunostaining techniques. Cell fate
experiments using a Pax2-cre mouse strain and an appro-
priate cre reporter strain would allow us to address which
type of neurotransmitter fate and properties the Pax2-pos-
itive septal neurons adopt.
In the developing eye, there is a sharp boundary between
the domains of Pax2 expression in the optic stalk and
Pax6 expression in the optic cup, [18,44,45]. Mutual
cross-repressive interactions between Pax2 and Pax6 are
essential for formation of this boundary [45]. Here we
show that Pax2 and Pax6 are expressed in neighbouring,
non-overlapping domains in the rostral telencephalon,
reminiscent of the pattern observed in the developing eyeBMC Developmental Biology 2008, 8:79 http://www.biomedcentral.com/1471-213X/8/79
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[18,45]. Given this expression pattern, and the fact that
the septum is enlarged in Pax6Sey/Sey mutants [15], we
hypothesised that the Pax2 septal expression domain
might be expanded in this mutant. However, we found no
increase in the extent or intensity of Pax2 expression in
this region in Pax6Sey/Sey mutants. Nevertheless, the Pax2
expression domain was found at a more dorsal position
than in the wild type, consistent with the previously
described size increase of the septum in the Pax6Sey/Sey
mutant [15]. The Pax2 expression domain still lies within
the ventral telencephalon, as shown by co-expression of
the septal marker Lim1 [26,27].
There are several mouse models with different types of
mutations in the Pax2 locus, including the Krd mice (Krd/
+), a mutant with a chromosomal deletion that includes
this locus [9,46,47], Pax2-/- null mutants [10,48], and
Pax21Neu mice with a frameshift mutation in Pax2 [49]. All
of these mutants display defects in kidney formation,
optic nerve trajectory, and inner ear patterning, consistent
with previously identified expression domains of Pax2
transcript [10,48-50]. However, defects in the midbrain-
hindbrain region range from complete loss of the poste-
rior mesencephalon and cerebellum in the Pax21Neu
mouse [49], to no phenotypic alteration in the Pax2-/-
mutant [10,51], possibly as a consequence of differences
in genetic background [10]. It would be of interest to
study the telencephalic septum in these different mutants,
to identify any possible alterations due to loss of Pax2
expression in this region.
Conclusion
Pax2 is expressed in the anterior hypothalamus, eminen-
tia thalami and telencephalic septum in the developing
mouse forebrain, in neuronal progenitors and early born
neurons. Between E11.5 and E14.5, it is strongly
expressed in the septal neuroepithelium, at a level close to
the lamina terminalis and it is no longer detectable by
P15. Further, the absence of functional Pax6 does not
cause gross alterations of Pax2 expression in the septum.
Thus Pax2 represents an ideal marker for the study of the
developing septum.
Methods
Mice
Animal care was in accordance with institutional guide-
lines and UK Home Office regulations. The day the vagi-
nal plug was detected was considered E0.5. Wild type mice
on a CBA genetic background were used for the Pax2
expression pattern analysis. Pax6Sey/+ heterozygotes, kept
on a mixed CD1-Swiss genetic background, were inter-
crossed to generate homozygous null embryos. These
were identified by the absence of eyes, as previously
described [13]. Wild type mice from the same genetic
background were collected for comparison by intercross-
ing wild types.
Histology
Embryos were harvested between E10.5 and E16.5 and
pups between P1 and P15. Whole embryos or heads of P1
were immersion fixed in 4% paraformaldehyde in 0.1 M
phosphate buffer overnight at 4°C. P7 and P15 pups were
anesthetized with Avertin and perfused through the heart
with fixative, followed by tissue dissection and overnight
incubation in fresh fix. Embryonic and postnatal tissue
were all processed following standard conditions [21],
embedded in paraffin and cut in serial 10 μm sections
(embryonic tissue) or 12.5 μm (postnatal brains) at a
coronal or sagittal plane. At least two wild type embryonic
heads or postnatal brains for each age were used, and six
Pax6Sey/Sey mutants with the corresponding wild types were
examined with each marker.
Immunohistochemistry and Immunofluorescence
These were performed according to standard protocols.
Antigen retrieval was achieved by microwaving sections at
full power in 10 mM citrate buffer, pH 6.0 for four times,
5 min each. Primary antibodies were rabbit anti-Pax2
(Covance, 1:200), rabbit anti-calbindin (Swant, 1:500),
monoclonal mouse anti-Pax6, Lim1/2 (DSHB, both
1:100) and nestin (DSHB, 1:50), and goat anti-choline
acetyltransferase (Millipore – AB144P, 1:50). Secondary
non-fluorescence antibodies were biotylinated anti-rabbit
IgG (Dako, 1:200), biotylinated anti-mouse IgG (Dako,
1:200), biotylinated anti-goat IgG (Dako, 1:100),
For single immunohistochemistry experiments the dark
brown signal was revealed after incubation with the ABC
kit (Vector), followed by standard diaminobenzidin
(DAB, Sigma) and hydrogen peroxide incubation. For the
double immunohistochemistry experiments, nuclear
staining was first detected using a DAB-nickel detection kit
(Vector) resulting in a grey/black staining. Sections were
then incubated with the second antibody and appropriate
secondary and the dark brown filamentous signal was
revealed after incubation with the ABC kit (Vector), fol-
lowed by a DAB reaction using the DAB detection kit (Vec-
tor). For the double immunofluorescence experiments,
Pax6 or Lim1/2 signal were amplified with a biotinylated
anti-mouse IgG antibody and signal was revealed after
incubating with streptavidin conjugated to Alexa fluor
488 dye (Invitrogen, 1:200). Monoclonal anti-β tubulin
isotype III (Sigma – clone SDL.3D10, 1:400) was detected
using as secondary antibody an anti-mouse IgG conju-
gated to Alexa fluor 488 dye (Invitrogen, 1:200). For dou-
ble immunohistochemistry followed by
immunofluorescence, after detection of the first antibody
with DAB or DAB-Nickel immunohistochemistry as
described above, sections were incubated with a secondBMC Developmental Biology 2008, 8:79 http://www.biomedcentral.com/1471-213X/8/79
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antibody which was detected by means of immunofluo-
rescence. Polyclonal Pax2 and calbindin were detected
using as secondary antibodies an anti-rabbit IgG conju-
gated to Alexa fluor 488 dye and an anti-rabbit IgG conju-
gated to Alexa fluor 568 dye, respectively (Invitrogen,
1:200). Appropriate controls were used in all cases by
incubating some sections with all but the primary anti-
bodies. No immunostaining occurred under these condi-
tions.
Microscopy
A Leica microscope connected to a Leica DFC 480 digital
camera was used to capture images of DAB and immun-
ofluorescent labelled sections. Confocal images were cap-
tured with a Leica TCS NT confocal microscope.
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